Juha‐Matti Savola

Characterization of the selectivity, specificity and potency of medetomidine as an α2-adrenoceptor agonist

Raimo Virtanen, Juha‐Matti Savola, Veijo Saano et al. · European Journal of Pharmacology · 1988 · 701 citations

Medicine, Medicinal Chemistry, Pharmacology +7

Highly selective and specific antagonism of central and peripheral alpha 2-adrenoceptors by atipamezole.

R Virtanen, Juha‐Matti Savola, Veijo Saano · PubMed · 1989 · 179 citations

Medicine, Pharmacology, Clinical Pharmacology +13

Fipamezole (JP‐1730) is a potent α₂ adrenergic receptor antagonist that reduces levodopa‐induced dyskinesia in the MPTP‐lesioned primate model of Parkinson's disease

Juha‐Matti Savola, Michael P. Hill, Mia Engström et al. · Movement Disorders · 2003 · 156 citations

Medicine, Neuroscience, Pharmacology +17

EVIDENCE FOR MEDETOMIDINE AS A SELECTIVE AND POTENT AGONIST α₂‐ADRENORECEPTORS

Juha‐Matti Savola, Heikki Ruskoaho, Juhani Puurunen et al. · Journal of Autonomic Pharmacology · 1986 · 146 citations

Medicine, Medicinal Chemistry, Pharmacology +11

Central α2-adrenoceptors are highly stereoselective for dexmedetomidine, the dextro enantiomer of medetomidine

Juha‐Matti Savola, Raimo Virtanen · European Journal of Pharmacology · 1991 · 137 citations

Medicine, Pharmacology, Pharmacodynamics +6